Genetic testing for UGT1A1*28 and *6 in Japanese patients who receive irinotecan chemotherapy.
Akiyama
Y
Y
Fujita
K
K
Nagashima
F
F
Yamamoto
W
W
Endo
H
H
Sunakawa
Y
Y
Yamashita
K
K
Ishida
H
H
Mizuno
K
K
Araki
K
K
Ichikawa
W
W
Miya
T
T
Narabayashi
M
M
Kawara
K
K
Sugiyama
M
M
Hirose
T
T
Ando
Y
Y
Sasaki
Y
Y
D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D044466:Asian People; D002166:Camptothecin / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D020022:Genetic Predisposition to Disease; D014453:Glucuronosyltransferase / Q000235:genetics*; D006801:Humans; D000077146:Irinotecan; D008297:Male; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D011110:Polymorphism, Genetic; D000099148:UGT1A1 Enzyme
D000972:Antineoplastic Agents, Phytogenic; D002166:Camptothecin; D014453:Glucuronosyltransferase; D000077146:Irinotecan; D000099148:UGT1A1 Enzyme